Compare NNNN & CRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | CRCT |
|---|---|---|
| Founded | 2021 | 1969 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Wholesale Distributors |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 2025 | 2021 |
| Metric | NNNN | CRCT |
|---|---|---|
| Price | $26.06 | $5.14 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $4.18 |
| AVG Volume (30 Days) | 26.9K | ★ 492.2K |
| Earning Date | 04-28-2026 | 11-04-2025 |
| Dividend Yield | N/A | ★ 18.27% |
| EPS Growth | N/A | ★ 27.98 |
| EPS | 0.06 | ★ 0.37 |
| Revenue | $8,185,146.00 | ★ $714,492,000.00 |
| Revenue This Year | N/A | $1.06 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $534.57 | ★ $14.07 |
| Revenue Growth | ★ 21.95 | N/A |
| 52 Week Low | $5.18 | $3.94 |
| 52 Week High | $55.65 | $7.33 |
| Indicator | NNNN | CRCT |
|---|---|---|
| Relative Strength Index (RSI) | 46.07 | 56.25 |
| Support Level | $26.89 | $4.65 |
| Resistance Level | $44.73 | $5.27 |
| Average True Range (ATR) | 5.72 | 0.14 |
| MACD | -0.32 | 0.06 |
| Stochastic Oscillator | 22.84 | 78.23 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.